Our findings that lncRNA MIR31HG stimulates GLI2 by WDR5/MLL3/P300-mediated active chromatin landscape highlight lncRNA MIR31HG as a potential target for clinical lung cancer clinic treatment (Fig. 7). Here, WDR5 is linked to lung carcinoma.